Anubha Bajaj
Follicular lymphoma may be defined as a B cell non-Hodgkin’s lymphoma where the lymphoid follicles of the neoplasm may simulate the typical secondary, activated follicles. It comprises of 40% of the adult lymphomas and 22% of the indolent no Hodgkin’s lymphomas of the developed world with greater than 1500 instances of annual prevalence. The disorder is infrequent in Africans and with adolescents (patients below 20 years of age). A nodular lymphocyte predominance Hodgkin’s disease (NLPHD) or a nodal reactive follicular hyperplasia (RFH) may replicate the disorder in children. A majority (80%) of individuals necessitate a therapeutic intervention on account of disease progression. An estimated one fifth (20%) of patients may survive in the absence of therapy for the first decade following detection.